These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22164433)

  • 1. [The loss of heterozygosity and microsatellite instability analysis in differential diagnostics of leiomyosarcoma and proliferative leiomyoma of the uterus].
    Shikeeva AA; Kekeeva TV; Zavalishina LÉ; Andreeva IuIu; Frank GA
    Arkh Patol; 2011; 73(4):47-50. PubMed ID: 22164433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
    Quade BJ; Pinto AP; Howard DR; Peters WA; Crum CP
    Am J Pathol; 1999 Mar; 154(3):945-50. PubMed ID: 10079273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
    Canevari Rde A; Pontes A; Rogatto SR
    Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign metastatic leiomyoma of the corpus uteri].
    Andreeva IuIu; Danilova NV; Shikeeva AA; Kekeeva TV; Zavalishina LE; Frank GA
    Arkh Patol; 2012; 74(6):39-43. PubMed ID: 23383444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization.
    Levy B; Mukherjee T; Hirschhorn K
    Cancer Genet Cytogenet; 2000 Aug; 121(1):1-8. PubMed ID: 10958933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
    Fletcher JA; Morton CC; Pavelka K; Lage JM
    Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
    Lee JH; Ryu TY; Cho CH; Kim DK
    Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.
    Zhai YL; Nikaido T; Orii A; Horiuchi A; Toki T; Fujii S
    Gynecol Oncol; 1999 Dec; 75(3):453-9. PubMed ID: 10600306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
    Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
    Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of loss of heterozygosity in serum microsatellite DNA of patients with gastrointestinal stromal tumors.
    Schurr PG; Oikonomou D; Kaifi JT; Merkert P; Wolter S; Kleinhans H; Reichelt U; Mann O; Gawad KA; Strate T; Yekebas EF; Izbicki JR
    J Clin Gastroenterol; 2009 Jan; 43(1):27-35. PubMed ID: 18469721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Smooth muscle tumors of uncertain malignant potential].
    Andreeva YY; Moskvina LV; Frank GA; Zavalishina LE; Babenko OV; Zhevlova AI; Kekeeva TV; Stilidi IS; Davydov MM; Payanidi YG; Kulik IO; Podberezina YL
    Arkh Patol; 2019; 81(3):5-11. PubMed ID: 31317925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
    Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
    Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma.
    Türkmen O; Müftüoğlu KH; Dinçer N; Çelik ZE; Akar Inan S
    Turk J Med Sci; 2024; 54(4):804-810. PubMed ID: 39295619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
    Al-Hendy A; Salama SA
    J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
    Rao UN; Finkelstein SD; Jones MW
    Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearrangement of band 10q22 in leiomyoma and leiomyosarcoma of the uterus.
    Kiechle-Schwarz M; Berger CS; Surti U; Sandberg AA
    Cancer Genet Cytogenet; 1990 Jul; 47(1):95-100. PubMed ID: 2357691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.
    Guo J; Zheng J; Tong J
    Int J Med Sci; 2024; 21(7):1227-1240. PubMed ID: 38818470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
    Lu T; Hano H
    Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.